From October 1, 2022 to December 31, 2022, the company has repurchased 30,388,779 shares, representing 1.43% for $2,298.77 million. With this, the company has completed the repurchase of 388,815,367 shares, representing 19.76% for $24,831.24 million under the buyback announced on October 27, 2016.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.86 USD | -0.27% | +2.13% | -4.77% |
Apr. 23 | Germany's Evotec appoints Christian Wojczewski as CEO | RE |
Apr. 23 | Novartis Nominates Former Bristol Myers Squibb CEO as New Chair | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.77% | 99.03B | |
+25.61% | 660B | |
+25.87% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+7.09% | 219B | |
-9.12% | 196B | |
+5.01% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Tranche Update on Bristol-Myers Squibb Company's Equity Buyback Plan announced on October 27, 2016.